Related Experiment Video
Updated: Feb 26, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Cysteine as a potential anti-amyloidogenic agent with protective ability against amyloid induced cytotoxicity
Masihuz Zaman1, Syed Mohammad Zakariya1, Saima Nusrat1
1Molecular Biophysics and Biophysical Chemistry Group, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Abstract:
Protein aggregation and misfolding have been allied with numerous human disorders and thus inhibition of such occurrence has been center for intense research efforts against these diseases. Here, we investigated anti-fibrillation activity of cysteine and its effect on kinetics of stem bromelain amyloid fibril formation. We established the anti-fibrillation and anti aggregation activities of cysteine by using multiple approaches like turbidity measurements, dye binding assays (ThT and ANS) and structural changes were monitored by circular dichroism (CD) followed by electron microscopy. Our experimental study inferred that cysteine inhibits temperature induced fibrillation of protein in a concentration dependent way. In addition, MDA-MB-231 cell viability of pre-formed amyloid was increased in presence of cysteine as compared to the fibrils alone. Furthermore, dynamic light scattering studies of native, aggregated as well as incubated (amyloids in presence of cysteine) samples indicates that cysteine restores native like structures of stem bromelain. Isothermal titration calorimetric results revealed that hydrogen bonding between cysteine and stem bromelain plays a significant role during inhibition of stem bromelain aggregation. However, thiophilic interaction between thiol group of cysteine and aromatic amino acid residue of stem bromelain may also have noteworthy role in inhibition of amyloid formation.
Insights
Cysteine effectively inhibits protein fibrillation and aggregation, restoring native-like structures. This finding offers potential therapeutic strategies for protein misfolding disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Biophysics
Background:
- Protein misfolding and aggregation are implicated in various human diseases.
- Inhibiting protein aggregation is a key research focus for disease treatment.
Purpose of the Study:
- To investigate the anti-fibrillation and anti-aggregation properties of cysteine.
- To understand cysteine's effect on the kinetics of stem bromelain amyloid fibril formation.
Main Methods:
- Turbidity measurements
- Thioflavin T (ThT) and Anilino-naphthalene-sulfonic acid (ANS) dye binding assays
- Circular Dichroism (CD) spectroscopy
- Electron Microscopy
- Dynamic Light Scattering (DLS)
- Isothermal Titration Calorimetry (ITC)
Main Results:
- Cysteine demonstrated concentration-dependent inhibition of temperature-induced protein fibrillation.
- Cysteine treatment increased the viability of MDA-MB-231 cells exposed to pre-formed amyloid fibrils.
- DLS studies indicated that cysteine restores stem bromelain to native-like structures.
- ITC results suggested that hydrogen bonding and thiophilic interactions are crucial for cysteine's inhibitory mechanism.
Conclusions:
- Cysteine exhibits significant anti-fibrillation and anti-aggregation activities against stem bromelain.
- Cysteine's mechanism involves restoring protein structure and potentially offers therapeutic benefits for protein misfolding diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Caspases

